Summaries for Patients |

What Is the Most Cost-Effective Way To Protect People in the Event of an Anthrax Terror Attack? FREE

[+] Article, Author, and Disclosure Information

The summary below is from the full report titled “Cost-Effectiveness of Defending against Bioterrorism: A Comparison of Vaccination and Antibiotic Prophylaxis against Anthrax.” It is in the 19 April 2005 issue of Annals of Internal Medicine (volume 142, pages 601-610). The authors are R.A. Fowler, G.D. Sanders, D.M. Bravata, B. Nouri, J.M. Gastwirth, D. Peterson, A.G. Broker, A.M. Garber, and D.K. Owens.

Ann Intern Med. 2005;142(8):I-40. doi:10.7326/0003-4819-142-8-200504190-00002
Text Size: A A A

What is the problem and what is known about it so far?

Anthrax is an infectious disease caused by bacteria that can survive for years as spores. It is usually found in animals, such as cattle, sheep, and goats. Although human cases are uncommon in the United States, people can get anthrax by inhaling spores from infected animals or animal products. Anthrax leads to breathing problems, serious illness, and often death. In 2001, anthrax spores were deliberately spread through the U.S. mail. The release of a large amount of anthrax spores into the air could harm many people, so terrorists could use anthrax in an attack. It is uncertain what would be the best way to protect people in such an attack. Antibiotics can help reduce serious anthrax illness, but they must be given early because the disease worsens rapidly. A vaccine for anthrax is available, but public health officials are reluctant to vaccinate the general population because of the vaccine's side effects and costs.

Why did the researchers do this particular study?

To determine the best way to protect people in the event of an anthrax terror attack, balancing issues of effectiveness, safety, and cost.

Who was studied?

The researchers did not study actual patients. Instead, they developed a computer simulation of an anthrax terrorist attack.

How was the study done?

The researchers used information from published studies and experts to estimate the number of people who might be exposed to anthrax if terrorists released anthrax into the air in a large U.S. city. They also estimated the number of people who would become sick or die from such an attack. Finally, they estimated the potential costs and benefits of several different strategies to protect people in the area of the attack. Officials could vaccinate people before an attack, with or without administering antibiotics after the attack. Officials could wait for an attack to occur and then vaccinate people after the attack, give people antibiotics, or both. Or officials could not vaccinate and not give antibiotics.

What did the researchers find?

Waiting for an attack and then giving people in the affected area both vaccination and antibiotics was the strategy that best balanced benefits, side effects, and costs.

What are the limitations of the study?

The researchers had a limited amount of anthrax research on which to base their computer model, so the conclusions about the best strategy might change as we learn more about anthrax. They also used decisions that officials would make for large groups of people, not decisions that individuals would make about their own treatment. The findings apply to large-scale urban attacks in which anthrax is released into the air; they do not apply to other forms of attack, such as that which occurred in the U.S. postal system in 2001.

What are the implications of the study?

The likelihood of a wide-scale attack is probably small; however, if an attack did occur, the best strategy would be to give persons potentially affected both antibiotics and a vaccine.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.